• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺炎期间p53蛋白的过表达。

Overexpression of p53 protein during pancreatitis.

作者信息

Maacke H, Kessler A, Schmiegel W, Roeder C, Vogel I, Deppert W, Kalthoff H

机构信息

Heinrich-Pette-Institut für Experimentelle Immunologie und Virologie, Universität Hamburg, Germany.

出版信息

Br J Cancer. 1997;75(10):1501-4. doi: 10.1038/bjc.1997.256.

DOI:10.1038/bjc.1997.256
PMID:9166944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2223499/
Abstract

Overexpression of p53 correlates with neoplasia in many cytological specimens. To test the specificity of overexpressed p53 as a tumour marker for the detection of pancreatic cancer, we analysed cytological specimens of pancreatic juice samples from patients with pancreatitis or pancreatic carcinoma (n = 42) for p53 protein overexpression. p53 protein overexpression was found in 59% of patients with pancreatitis and 67% of patients with pancreatic carcinoma. Thus, the assessment of p53 protein overexpression is not useful in the diagnosis of pancreatic cancer. Overexpressed p53 during pancreatitis appears to be wild-type p53. Overexpression of p53 may result from DNA damage occurring during chronic inflammation. It is well established that p53 can induce apoptosis upon DNA damage. Consequently, we found apoptotic cell death in five out of five tested cytological preparations from patients with pancreatitis as well as in one out of one pancreatic carcinoma specimen.

摘要

在许多细胞学标本中,p53的过表达与肿瘤形成相关。为了测试过表达的p53作为检测胰腺癌的肿瘤标志物的特异性,我们分析了胰腺炎或胰腺癌患者(n = 42)的胰液样本的细胞学标本中p53蛋白的过表达情况。在59%的胰腺炎患者和67%的胰腺癌患者中发现了p53蛋白过表达。因此,评估p53蛋白过表达对胰腺癌的诊断并无帮助。胰腺炎期间过表达的p53似乎是野生型p53。p53的过表达可能源于慢性炎症期间发生的DNA损伤。众所周知,p53可在DNA损伤时诱导细胞凋亡。因此,我们在来自胰腺炎患者的五个测试细胞学制剂中的五个以及在一个胰腺癌标本中发现了凋亡细胞死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03c8/2223499/30215c6974e4/brjcancer00187-0105-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03c8/2223499/f96926d22cca/brjcancer00187-0104-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03c8/2223499/30215c6974e4/brjcancer00187-0105-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03c8/2223499/f96926d22cca/brjcancer00187-0104-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03c8/2223499/30215c6974e4/brjcancer00187-0105-a.jpg

相似文献

1
Overexpression of p53 protein during pancreatitis.胰腺炎期间p53蛋白的过表达。
Br J Cancer. 1997;75(10):1501-4. doi: 10.1038/bjc.1997.256.
2
p53 protein expression and CA19.9 values in differential cytological diagnosis of pancreatic cancer complicated with chronic pancreatitis and chronic pancreatitis.p53蛋白表达及CA19.9值在胰腺癌合并慢性胰腺炎与慢性胰腺炎鉴别细胞学诊断中的应用
World J Gastroenterol. 2003 Aug;9(8):1815-8. doi: 10.3748/wjg.v9.i8.1815.
3
p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis.慢性胰腺炎患者胰液样本中的p53和K-ras突变
Gastrointest Endosc. 2001 Jun;53(7):734-43. doi: 10.1067/mge.2001.112711.
4
Double immunohistochemical staining with MUC4/p53 is useful in the distinction of pancreatic adenocarcinoma from chronic pancreatitis: a tissue microarray-based study.MUC4/p53双重免疫组化染色在鉴别胰腺腺癌与慢性胰腺炎中具有重要作用:一项基于组织芯片的研究
Arch Pathol Lab Med. 2007 Apr;131(4):556-62. doi: 10.5858/2007-131-556-DISWPI.
5
Immunohistochemical demonstration of the p53 tumour suppressor gene product in cancer of the pancreas and chronic pancreatitis.免疫组织化学法显示胰腺肿瘤及慢性胰腺炎中p53肿瘤抑制基因产物
J Gastroenterol Hepatol. 1993 Sep-Oct;8(5):465-9. doi: 10.1111/j.1440-1746.1993.tb01550.x.
6
Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma.胰液中组织蛋白酶E在胰腺导管腺癌诊断中的临床意义
J Gastroenterol Hepatol. 2000 Nov;15(11):1333-8.
7
ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma.ADAM9在胰腺癌中的表达与肿瘤类型相关,并且是导管腺癌的一个预后因素。
Br J Cancer. 2004 Mar 8;90(5):1053-8. doi: 10.1038/sj.bjc.6601645.
8
Immunohistochemical analysis of p53 and MIB-1 in tissue specimens obtained from endoscopic ultrasonography-guided fine needle aspiration biopsy for the diagnosis of solid pancreatic masses.对通过内镜超声引导下细针穿刺活检获取的组织标本进行p53和MIB-1的免疫组织化学分析,以诊断实性胰腺肿块。
Oncol Rep. 2005 Feb;13(2):229-34.
9
Preproenkephalin hypermethylation in the pure pancreatic juice compared with p53 mutation in the diagnosis of pancreatic carcinoma.与p53突变相比,前脑啡肽原在纯胰液中的高甲基化在胰腺癌诊断中的作用。
J Gastroenterol. 2006 Aug;41(8):791-7. doi: 10.1007/s00535-006-1857-3.
10
Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis.使用定量蛋白质组学分析比较癌症与胰腺炎患者的胰液蛋白质
Pancreas. 2007 Jan;34(1):70-9. doi: 10.1097/01.mpa.0000240615.20474.fd.

引用本文的文献

1
p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer.p53 抑制剂 iASPP 是 KRAS 和炎症驱动的胰腺癌的意外抑制剂。
Cell Death Differ. 2023 Jul;30(7):1619-1635. doi: 10.1038/s41418-023-01168-3. Epub 2023 Jun 3.
2
A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three Patients.一项个体化自体树突状细胞疫苗、阿司匹林联合标准辅助化疗,序贯纳武利尤单抗治疗可切除胰腺导管腺癌的 Ib 期研究:三例患者的抗原发现可行性验证
Front Immunol. 2019 Aug 8;10:1832. doi: 10.3389/fimmu.2019.01832. eCollection 2019.
3

本文引用的文献

1
Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors.胰腺肿瘤中p16/MTS1和p15/MTS2的频繁共缺失以及p16/MTS1的基因改变。
Gastroenterology. 1996 Apr;110(4):1215-24. doi: 10.1053/gast.1996.v110.pm8613012.
2
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1.DPC4,一种位于人类18号染色体q21.1区域的候选抑癌基因。
Science. 1996 Jan 19;271(5247):350-3. doi: 10.1126/science.271.5247.350.
3
Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease.
Advances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancer.使用基于细胞的癌症疫苗诱导适应性免疫的进展:在胰腺癌中的临床应用
World J Gastroenterol. 2016 May 14;22(18):4446-58. doi: 10.3748/wjg.v22.i18.4446.
4
Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.胰腺癌:免疫系统在癌症进展及基于疫苗的免疫治疗中的作用
Hum Vaccin Immunother. 2014;10(11):3354-68. doi: 10.4161/hv.34392.
5
What is recent in pancreatic cancer immunotherapy?胰腺癌免疫治疗的新进展是什么?
Biomed Res Int. 2013;2013:492372. doi: 10.1155/2013/492372. Epub 2012 Dec 26.
6
Current immunotherapeutic approaches in pancreatic cancer.胰腺癌当前的免疫治疗方法。
Clin Dev Immunol. 2011;2011:267539. doi: 10.1155/2011/267539. Epub 2011 Sep 14.
7
Staining for p53 and Ki-67 increases the sensitivity of EUS-FNA to detect pancreatic malignancy.p53和Ki-67染色可提高超声内镜引导下细针穿刺活检(EUS-FNA)检测胰腺恶性肿瘤的敏感性。
World J Gastrointest Endosc. 2010 Nov 16;2(11):362-8. doi: 10.4253/wjge.v2.i11.362.
8
Mitochondrial dysfunction and apoptosis of acinar cells in chronic pancreatitis.慢性胰腺炎中腺泡细胞的线粒体功能障碍与凋亡
J Gastroenterol. 2008;43(6):473-83. doi: 10.1007/s00535-008-2179-4. Epub 2008 Jul 4.
9
Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors.胃肠道肿瘤中根据p53状态对分离出的肿瘤细胞进行形态学和免疫组织化学特征分析。
Langenbecks Arch Surg. 2008 Jan;393(1):49-58. doi: 10.1007/s00423-007-0218-x. Epub 2007 Sep 18.
10
p53 tumor suppressor gene mutations in fibroblast-like synoviocytes from erosion synovium and non-erosion synovium in rheumatoid arthritis.类风湿关节炎中侵蚀性滑膜和非侵蚀性滑膜的成纤维样滑膜细胞中的p53肿瘤抑制基因突变
Arthritis Res Ther. 2005;7(1):R12-8. doi: 10.1186/ar1448. Epub 2004 Oct 29.
无胰腺疾病的胰腺增生导管细胞中K-ras基因突变分析
Gastroenterology. 1996 Jan;110(1):227-31. doi: 10.1053/gast.1996.v110.pm8536861.
4
Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.胰腺炎与胰腺癌风险。国际胰腺炎研究小组。
N Engl J Med. 1993 May 20;328(20):1433-7. doi: 10.1056/NEJM199305203282001.
5
p53 and K-RAS alterations in pancreatic epithelial cell lesions.胰腺上皮细胞病变中的p53和K-RAS改变
Oncogene. 1993 Feb;8(2):289-98.
6
Redox modulation of p53 conformation and sequence-specific DNA binding in vitro.体外p53构象的氧化还原调节及序列特异性DNA结合
Cancer Res. 1993 Oct 1;53(19):4469-73.
7
Clinical utility of the immunocytochemical detection of p53 protein in cytological specimens.
Cancer Res. 1994 Jun 1;54(11):2914-8.
8
Pancreatitis and pancreatic cancer: a population-based study.胰腺炎与胰腺癌:一项基于人群的研究。
J Natl Cancer Inst. 1994 Apr 20;86(8):625-7. doi: 10.1093/jnci/86.8.625.
9
High levels of p53 protein in UV-irradiated normal human skin.紫外线照射后的正常人类皮肤中p53蛋白水平较高。
Oncogene. 1993 Jan;8(1):203-7.
10
Detection of the anti-p53 antibody response in malignant and benign pancreatic disease.恶性和良性胰腺疾病中抗p53抗体反应的检测
Br J Cancer. 1994 Nov;70(5):1031-4. doi: 10.1038/bjc.1994.443.